AVXL Operating Cash Flow (Statement)
Anavex Life Sciences Corp · Operating Cash Flow (Statement)
AVXL Operating Cash Flow (Statement)
Latest reported-$33.73Mperiod ending
AVXL TTM Cash from Operations (-$61.07K → -$33.73M)
TTM operating cash flow (statement)
High-resolution chart · PNG
AVXL operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -33,731,000 | |
| -32,659,000 | |
| -34,075,000 | |
| -39,044,000 | |
| -37,098,000 | |
| -29,814,000 | |
| -35,614,000 | |
| -30,812,000 | |
| -30,003,629 | |
| -32,476,629 | |
| -29,309,629 | |
| -27,785,629 | |
| -25,979,935 | |
| -25,380,425 | |
| -26,530,909 | |
| -24,237,864 | |
| -27,868,437 | |
| -28,335,890 | |
| -26,013,251 | |
| -30,383,674 | |
| -28,963,938 | |
| -25,487,218 | |
| -23,433,265 | |
| -21,287,046 | |
| -17,566,580 | |
| -21,023,541 | |
| -20,092,107 | |
| -18,527,117 | |
| -20,045,983 | |
| -14,632,933 | |
| -13,122,442 | |
| -12,582,406 | |
| -10,721,117 | |
| -11,606,963 | |
| -9,483,738 | |
| -9,017,231 | |
| -8,688,615 | |
| -7,938,442 | |
| -9,143,257 | |
| -9,236,823 | |
| -8,806,915 | |
| -8,013,404 | |
| -6,781,128 | |
| -4,227,006 | |
| -3,710,502 | |
| -3,240,211 | |
| -2,917,459 | |
| -2,659,379 | |
| -2,227,032 | |
| -1,299,217 | |
| -1,080,990 | |
| -777,573 | |
| -544,998 | |
| -751,510 | |
| -736,390 | |
| -1,692,940 | |
| -2,363,596 | |
| -3,330,881 | |
| -3,805,641 | |
| -3,801,479 | |
| -4,542,476 | |
| -4,435,537 | |
| -4,897,589 | |
| -4,593,588 | |
| -3,901,344 | |
| -3,983,682 | |
| -3,306,291 | |
| -2,794,655 | |
| -2,587,765 | |
| -2,003,937 | |
| -2,065,934 | |
| -2,474,053 | |
| -1,769,694 | |
| -1,375,040 | |
| -993,934 | |
| -325,250 | |
| -306,428 | |
| -76,387 | |
| -39,101 | |
| -32,428 | |
| -11,698 | |
| -38,835 | |
| -61,072 | |
| -61,072 |